ACE2-TMPRSS2 co-enhanced RT4 Cell Line (CAT#: VCeL-Wyb051)

  • Product Overview
  • ACE2-TMPRSS2 co-enhanced human bladder carcinoma cell
  • Quantity
  • 3-5×106 cells/ml
  • Target
  • SARS-CoV-2
  • Applications
  • Effective tools for studying COVID-19 drugs and vaccines.
  • Cell Type
  • ACE2-TMPRSS2 co-enhanced cell line
  • Organism
  • RT4 cells
  • Growth Properties
  • Adherent
  • Fluid Renewal
  • 2 to 3 times / week
  • Form
  • Frozen Cryovial
  • Biosafety Level
  • 1
  • Alternative Names
  • ACE2-TMPRSS2 co-enhanced RT4 Cell Line

Related products

Online Inquiry For Research Use Only. We do not provide services or products directly for patients.
  • Verification code
    Click image to refresh the verification code.

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.


Inquiry Basket